Last $46.06 USD
Change Today +0.02 / 0.04%
Volume 104.8K
HRC On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

hill-rom holdings inc (HRC) Snapshot

Open
$46.25
Previous Close
$46.04
Day High
$46.41
Day Low
$45.90
52 Week High
12/8/14 - $47.32
52 Week Low
02/5/14 - $34.94
Market Cap
2.6B
Average Volume 10 Days
302.2K
EPS TTM
$1.49
Shares Outstanding
57.5M
EX-Date
12/11/14
P/E TM
30.9x
Dividend
$0.61
Dividend Yield
1.32%
Current Stock Chart for HILL-ROM HOLDINGS INC (HRC)

hill-rom holdings inc (HRC) Related Businessweek News

No Related Businessweek News Found

hill-rom holdings inc (HRC) Details

Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. The company operates through three segments: North America, Surgical and Respiratory Care, and International. It provides patient care systems, including various bed systems, as well as mobility solutions; and patient/resident room solutions, which include architectural products and health care furniture. The company also rents and sells non-invasive therapeutic products and surfaces for the prevention and treatment of various acute and chronic medical conditions, including pulmonary, wound, and bariatric conditions; and provides rentals and health care provider asset management services for moveable medical equipment, such as ventilators, defibrillators, intravenous pumps, and patient monitoring equipment. In addition, it offers surgical products, such as surgical tables, lights, and pendants utilized within the operating rooms; positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables; operating room disposable products, such as scalpels and blades, light handle systems, skin markers, and other disposable products; and therapeutic products that provide bronchial hygiene for acute and home care patients. Further, the company develops and markets various communications technologies and software solutions to enhance patient safety and efficiency at the point of care. It sells and rents its products primarily to acute and extended care facilities through direct sales force and distributors, as well as sells its products to patients in the home. Hill-Rom Holdings, Inc. was founded in 1969 and is headquartered in Batesville, Indiana.

7,325 Employees
Last Reported Date: 11/19/14
Founded in 1969

hill-rom holdings inc (HRC) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $942.6K
Senior Vice President and President of Intern...
Total Annual Compensation: $399.4K
Chief Legal Officer, Senior Vice President of...
Total Annual Compensation: $443.7K
Vice President and Treasurer
Total Annual Compensation: $208.9K
Senior Vice President of Corporate Developmen...
Total Annual Compensation: $335.5K
Compensation as of Fiscal Year 2013.

hill-rom holdings inc (HRC) Key Developments

Hill-Rom Holdings, Inc. Declares Fiscal Year 2015 First Quarter Dividend, Payable on December 29, 2014

Hill-Rom Holdings, Inc. announced that its board of directors declared a fiscal year 2015 first quarter dividend of $0.1525 per share. The dividend is payable on December 29, 2014 to shareholders of record as of the close of business on December 15, 2014.

Hill-Rom Holdings, Inc. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-02-2014 09:00 AM

Hill-Rom Holdings, Inc. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-02-2014 09:00 AM. Venue: The New York Palace Hotel, 455 Madison Ave, New York, NY 10022, United States.

Hill-Rom Holdings, Inc. Reports Consolidated Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2014; Provides Earnings Guidance for the First Quarter and Full Year of Fiscal 2015

Hill-Rom Holdings, Inc. reported consolidated earnings results for the fourth quarter and full year ended September 30, 2014. For the quarter, the company’s adjusted earnings per diluted share of $0.74 increased 4% from $0.71 in the prior year, while reported earnings per diluted share of $0.42 decreased 29% from $0.59. Revenue was $479.8 million, a 10% increase compared to $437.9 million for the last year on both a reported and constant currency basis, primarily due to the Trumpf Medical acquisition which closed on August 1, 2014. Operating profit was $35.4 million compared to $48.1 million a year ago. Net income was $24.6 million compared to $35.3 million a year ago. For the full year, the company’s revenue was $1,686 million compared to $1,716 million for the prior year, a decrease of 2% on both a reported and constant currency basis. Adjusted earnings per diluted share for fiscal 2014 were $2.25 compared to $2.38 in 2013, a decrease of 5%. Reported earnings per diluted share for the full year were $1.04 compared to $1.74 for the prior year. Operating profit was $122.6 million compared to $154.9 million a year ago. Net income was $60.6 million compared to $105.0 million a year ago. Net cash provided by operating activities was $210.3 million compared to $263.2 million a year ago, down primarily due to lower earnings and a lower contribution from working capital, including outflows from the company’s restructuring actions. Capital expenditures and purchases of intangible assets were $62.7 million compared to $65.3 million a year ago. The company provided earnings guidance for the first quarter and full year of fiscal 2015. For the first quarter of fiscal 2015, the company expects reported revenue growth of 14 to 16%. This reflects, low single-digit constant currency organic growth; negative currency impact of approximately 2% at current rates; and revenue contribution from Trumpf Medical. First quarter adjusted earnings per diluted share are expected to be $0.44 to $0.48. The company expects fiscal year 2015 revenue to grow 11% to 13%. This reflects low single digit constant currency organic revenue growth, a negative impact from currency of between 1% and 2% at current rates and full year revenue contribution from TRUMPF. Adjusted earnings per diluted share are expected to be $2.42 to $2.48. The company expects cash flow from operations for the full year to be approximately $250 million. The company also anticipates approximately $110 million of CapEx investment for the full year. The year-over-year increase is driven by the need to invest in the company’s rental fleet to support volume increases from recent contract wins as well as the addition of TRUMPF capital expenditures.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HRC:US $46.06 USD +0.02

HRC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Integra LifeSciences Holdings Corp $53.90 USD +0.22
Invacare Corp $16.73 USD -0.07
PerkinElmer Inc $44.07 USD +0.08
STERIS Corp $66.70 USD -0.06
Teleflex Inc $116.79 USD -0.03
View Industry Companies
 

Industry Analysis

HRC

Industry Average

Valuation HRC Industry Range
Price/Earnings 44.5x
Price/Sales 1.6x
Price/Book 3.3x
Price/Cash Flow 43.7x
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HILL-ROM HOLDINGS INC, please visit www.hill-rom.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.